Structure

Physi-Chem Properties

Molecular Weight:  650.43
Volume:  738.877
LogP:  11.688
LogD:  7.198
LogS:  -4.868
# Rotatable Bonds:  14
TPSA:  62.83
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.17
Synthetic Accessibility Score:  4.435
Fsp3:  0.455
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.179
MDCK Permeability:  1.4214416296454147e-05
Pgp-inhibitor:  0.24
Pgp-substrate:  0.817
Human Intestinal Absorption (HIA):  0.067
20% Bioavailability (F20%):  0.941
30% Bioavailability (F30%):  0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  103.0304946899414%
Volume Distribution (VD):  3.019
Pgp-substrate:  2.9943981170654297%

ADMET: Metabolism

CYP1A2-inhibitor:  0.175
CYP1A2-substrate:  0.161
CYP2C19-inhibitor:  0.575
CYP2C19-substrate:  0.112
CYP2C9-inhibitor:  0.737
CYP2C9-substrate:  0.985
CYP2D6-inhibitor:  0.354
CYP2D6-substrate:  0.158
CYP3A4-inhibitor:  0.172
CYP3A4-substrate:  0.123

ADMET: Excretion

Clearance (CL):  4.679
Half-life (T1/2):  0.018

ADMET: Toxicity

hERG Blockers:  0.203
Human Hepatotoxicity (H-HT):  0.99
Drug-inuced Liver Injury (DILI):  0.75
AMES Toxicity:  0.018
Rat Oral Acute Toxicity:  0.059
Maximum Recommended Daily Dose:  0.915
Skin Sensitization:  0.957
Carcinogencity:  0.03
Eye Corrosion:  0.003
Eye Irritation:  0.273
Respiratory Toxicity:  0.606

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC227906

Natural Product ID:  NPC227906
Common Name*:   Albatrelin D
IUPAC Name:   (3R)-3-[(3E)-4,8-dimethylnona-3,7-dienyl]-3,6,7-trimethyl-10-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-[1]benzofuro[2,3-f]chromene-5,9-diol
Synonyms:   Albatrelin D
Standard InCHIKey:  URKKJJQZOARVCY-IMZRLPGDSA-N
Standard InCHI:  InChI=1S/C44H58O4/c1-28(2)15-11-17-30(5)19-13-20-32(7)22-23-35-37(45)27-33(8)38-39-34(9)40(46)43-36(42(39)47-41(35)38)24-26-44(10,48-43)25-14-21-31(6)18-12-16-29(3)4/h15-16,19,21-22,24,26-27,45-46H,11-14,17-18,20,23,25H2,1-10H3/b30-19+,31-21+,32-22+/t44-/m1/s1
SMILES:  CC(=CCC/C(=C/CC/C(=C/Cc1c(cc(C)c2c3c(C)c(c4c(C=C[C@@](C)(CC/C=C(C)/CCC=C(C)C)O4)c3oc12)O)O)/C)/C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2332226
PubChem CID:   71524351
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10941 Albatrellus ovinus Species Albatrellaceae Eukaryota n.a. n.a. n.a. PMID[23305465]
NPO10941 Albatrellus ovinus Species Albatrellaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10941 Albatrellus ovinus Species Albatrellaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 > 40000.0 nM PMID[538496]
NPT81 Cell Line A549 Homo sapiens IC50 > 40000.0 nM PMID[538496]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 40000.0 nM PMID[538496]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 40000.0 nM PMID[538496]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC227906 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.939 High Similarity NPC37870
0.9387 High Similarity NPC270837
0.9341 High Similarity NPC310794
0.9333 High Similarity NPC126204
0.9329 High Similarity NPC39306
0.9325 High Similarity NPC294965
0.9273 High Similarity NPC39091
0.9268 High Similarity NPC207690
0.9268 High Similarity NPC23298
0.9268 High Similarity NPC236132
0.9268 High Similarity NPC133065
0.9268 High Similarity NPC189473
0.9264 High Similarity NPC66288
0.9231 High Similarity NPC49667
0.9231 High Similarity NPC8127
0.9222 High Similarity NPC101107
0.9217 High Similarity NPC247973
0.9212 High Similarity NPC472450
0.9212 High Similarity NPC239752
0.9212 High Similarity NPC275780
0.9207 High Similarity NPC84515
0.9207 High Similarity NPC312056
0.9202 High Similarity NPC119224
0.9202 High Similarity NPC320359
0.9176 High Similarity NPC77179
0.9176 High Similarity NPC23553
0.9162 High Similarity NPC475805
0.9162 High Similarity NPC476637
0.9157 High Similarity NPC277480
0.9157 High Similarity NPC170245
0.9157 High Similarity NPC472449
0.9146 High Similarity NPC40491
0.9146 High Similarity NPC61010
0.9146 High Similarity NPC188486
0.9146 High Similarity NPC278052
0.9141 High Similarity NPC100123
0.9118 High Similarity NPC216307
0.9112 High Similarity NPC82217
0.9112 High Similarity NPC65885
0.9112 High Similarity NPC216842
0.9112 High Similarity NPC476640
0.9112 High Similarity NPC473834
0.9102 High Similarity NPC50394
0.9102 High Similarity NPC218226
0.9102 High Similarity NPC470704
0.9096 High Similarity NPC326520
0.9096 High Similarity NPC37183
0.9091 High Similarity NPC25152
0.9091 High Similarity NPC329760
0.9091 High Similarity NPC229632
0.9085 High Similarity NPC56085
0.9085 High Similarity NPC471973
0.9085 High Similarity NPC14353
0.9085 High Similarity NPC204290
0.9085 High Similarity NPC139036
0.9085 High Similarity NPC228785
0.9085 High Similarity NPC476980
0.908 High Similarity NPC136674
0.908 High Similarity NPC268360
0.908 High Similarity NPC236796
0.9064 High Similarity NPC221820
0.9059 High Similarity NPC287243
0.9053 High Similarity NPC54098
0.9053 High Similarity NPC230619
0.9053 High Similarity NPC174700
0.9048 High Similarity NPC247136
0.9042 High Similarity NPC43319
0.9036 High Similarity NPC7483
0.9036 High Similarity NPC152659
0.9036 High Similarity NPC236521
0.9036 High Similarity NPC248638
0.9036 High Similarity NPC475985
0.9036 High Similarity NPC197168
0.9036 High Similarity NPC220313
0.9034 High Similarity NPC60848
0.903 High Similarity NPC474351
0.903 High Similarity NPC259456
0.903 High Similarity NPC278427
0.903 High Similarity NPC475883
0.903 High Similarity NPC29876
0.903 High Similarity NPC167678
0.903 High Similarity NPC474187
0.9024 High Similarity NPC196879
0.9024 High Similarity NPC474290
0.9024 High Similarity NPC16935
0.9024 High Similarity NPC476242
0.9018 High Similarity NPC191146
0.9018 High Similarity NPC68093
0.9018 High Similarity NPC274730
0.9018 High Similarity NPC142339
0.9017 High Similarity NPC246153
0.9017 High Similarity NPC240508
0.9017 High Similarity NPC228209
0.9012 High Similarity NPC476631
0.8994 High Similarity NPC476641
0.8994 High Similarity NPC131866
0.8982 High Similarity NPC25361
0.8982 High Similarity NPC36320
0.8982 High Similarity NPC303174
0.8982 High Similarity NPC45449
0.8982 High Similarity NPC156432
0.8976 High Similarity NPC83922
0.8976 High Similarity NPC81679
0.8976 High Similarity NPC472448
0.8976 High Similarity NPC470694
0.8976 High Similarity NPC201800
0.897 High Similarity NPC235018
0.897 High Similarity NPC200746
0.897 High Similarity NPC80375
0.897 High Similarity NPC474287
0.897 High Similarity NPC475886
0.897 High Similarity NPC45146
0.8963 High Similarity NPC476981
0.8963 High Similarity NPC300727
0.8963 High Similarity NPC165977
0.8963 High Similarity NPC246647
0.8963 High Similarity NPC217677
0.8963 High Similarity NPC273843
0.8963 High Similarity NPC96342
0.8963 High Similarity NPC212967
0.8963 High Similarity NPC164110
0.8963 High Similarity NPC476630
0.8963 High Similarity NPC78225
0.8963 High Similarity NPC241904
0.8963 High Similarity NPC218871
0.8957 High Similarity NPC472280
0.8957 High Similarity NPC297531
0.8957 High Similarity NPC99199
0.8957 High Similarity NPC213936
0.8953 High Similarity NPC297807
0.8951 High Similarity NPC249570
0.8929 High Similarity NPC53640
0.8922 High Similarity NPC59295
0.8922 High Similarity NPC477689
0.8922 High Similarity NPC303460
0.8922 High Similarity NPC1706
0.8922 High Similarity NPC306321
0.8922 High Similarity NPC1755
0.8922 High Similarity NPC263092
0.8922 High Similarity NPC186686
0.8922 High Similarity NPC39305
0.8922 High Similarity NPC146134
0.8916 High Similarity NPC258331
0.8916 High Similarity NPC32694
0.8916 High Similarity NPC474186
0.8916 High Similarity NPC311740
0.8909 High Similarity NPC235448
0.8908 High Similarity NPC150977
0.8908 High Similarity NPC8927
0.8902 High Similarity NPC183843
0.8902 High Similarity NPC13779
0.8902 High Similarity NPC45131
0.8902 High Similarity NPC180924
0.8902 High Similarity NPC475799
0.8902 High Similarity NPC476273
0.8902 High Similarity NPC472455
0.8902 High Similarity NPC138243
0.8902 High Similarity NPC471985
0.8902 High Similarity NPC472907
0.8902 High Similarity NPC276444
0.8896 High Similarity NPC69394
0.8896 High Similarity NPC235333
0.8896 High Similarity NPC231018
0.8896 High Similarity NPC472462
0.8896 High Similarity NPC47781
0.8896 High Similarity NPC72370
0.8896 High Similarity NPC160951
0.8896 High Similarity NPC176775
0.8896 High Similarity NPC22519
0.8896 High Similarity NPC183878
0.8896 High Similarity NPC145379
0.8896 High Similarity NPC274327
0.8896 High Similarity NPC89474
0.8896 High Similarity NPC255350
0.8895 High Similarity NPC164384
0.8889 High Similarity NPC30550
0.8889 High Similarity NPC261471
0.8882 High Similarity NPC78830
0.8882 High Similarity NPC472276
0.8882 High Similarity NPC109827
0.8882 High Similarity NPC124470
0.8882 High Similarity NPC218533
0.8876 High Similarity NPC6588
0.8876 High Similarity NPC477154
0.8876 High Similarity NPC117854
0.887 High Similarity NPC295436
0.8869 High Similarity NPC29411
0.8869 High Similarity NPC473286
0.8869 High Similarity NPC26386
0.8869 High Similarity NPC293319
0.8864 High Similarity NPC240808
0.8862 High Similarity NPC238995
0.8862 High Similarity NPC474162
0.8862 High Similarity NPC472402
0.8862 High Similarity NPC261470
0.8862 High Similarity NPC474150
0.8862 High Similarity NPC272722
0.8857 High Similarity NPC476170
0.8855 High Similarity NPC328102
0.8855 High Similarity NPC246478

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC227906 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8896 High Similarity NPD2801 Approved
0.8706 High Similarity NPD7473 Discontinued
0.8639 High Similarity NPD6232 Discontinued
0.8554 High Similarity NPD2393 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD1934 Approved
0.8457 Intermediate Similarity NPD1511 Approved
0.8452 Intermediate Similarity NPD3882 Suspended
0.8412 Intermediate Similarity NPD5494 Approved
0.8391 Intermediate Similarity NPD5844 Phase 1
0.8354 Intermediate Similarity NPD1512 Approved
0.8333 Intermediate Similarity NPD3818 Discontinued
0.8256 Intermediate Similarity NPD1247 Approved
0.8218 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8218 Intermediate Similarity NPD6166 Phase 2
0.8218 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD3749 Approved
0.8182 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD6959 Discontinued
0.8146 Intermediate Similarity NPD6559 Discontinued
0.8132 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD7819 Suspended
0.8079 Intermediate Similarity NPD7054 Approved
0.8072 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD3817 Phase 2
0.8057 Intermediate Similarity NPD3926 Phase 2
0.8034 Intermediate Similarity NPD7074 Phase 3
0.8034 Intermediate Similarity NPD7472 Approved
0.8012 Intermediate Similarity NPD1465 Phase 2
0.8 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD2533 Approved
0.7964 Intermediate Similarity NPD2532 Approved
0.7964 Intermediate Similarity NPD2534 Approved
0.7941 Intermediate Similarity NPD4380 Phase 2
0.7931 Intermediate Similarity NPD919 Approved
0.7919 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD7808 Phase 3
0.7874 Intermediate Similarity NPD7075 Discontinued
0.7845 Intermediate Similarity NPD7251 Discontinued
0.7803 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.779 Intermediate Similarity NPD6797 Phase 2
0.7778 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD2800 Approved
0.7758 Intermediate Similarity NPD2344 Approved
0.7754 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD7768 Phase 2
0.7692 Intermediate Similarity NPD7390 Discontinued
0.7676 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD3226 Approved
0.767 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD1243 Approved
0.7661 Intermediate Similarity NPD920 Approved
0.7651 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD6801 Discontinued
0.7636 Intermediate Similarity NPD1510 Phase 2
0.7636 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD8434 Phase 2
0.763 Intermediate Similarity NPD6599 Discontinued
0.7627 Intermediate Similarity NPD6234 Discontinued
0.7622 Intermediate Similarity NPD1607 Approved
0.7619 Intermediate Similarity NPD3750 Approved
0.7611 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD943 Approved
0.7605 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD1549 Phase 2
0.7596 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD6099 Approved
0.759 Intermediate Similarity NPD2796 Approved
0.759 Intermediate Similarity NPD6100 Approved
0.7586 Intermediate Similarity NPD7411 Suspended
0.7574 Intermediate Similarity NPD2309 Approved
0.7557 Intermediate Similarity NPD5402 Approved
0.7545 Intermediate Similarity NPD2346 Discontinued
0.7544 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD7199 Phase 2
0.75 Intermediate Similarity NPD1240 Approved
0.7485 Intermediate Similarity NPD6799 Approved
0.7485 Intermediate Similarity NPD2935 Discontinued
0.7474 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD8312 Approved
0.7473 Intermediate Similarity NPD8313 Approved
0.7459 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD7783 Phase 2
0.745 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD37 Approved
0.7442 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD7228 Approved
0.7427 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD4625 Phase 3
0.7416 Intermediate Similarity NPD4967 Phase 2
0.7416 Intermediate Similarity NPD4965 Approved
0.7416 Intermediate Similarity NPD4966 Approved
0.7403 Intermediate Similarity NPD7229 Phase 3
0.7403 Intermediate Similarity NPD5711 Approved
0.7403 Intermediate Similarity NPD5710 Approved
0.7362 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD8150 Discontinued
0.735 Intermediate Similarity NPD8151 Discontinued
0.7337 Intermediate Similarity NPD3751 Discontinued
0.7326 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7870 Phase 2
0.7323 Intermediate Similarity NPD7871 Phase 2
0.7321 Intermediate Similarity NPD3748 Approved
0.731 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD3787 Discontinued
0.7301 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD6781 Approved
0.7296 Intermediate Similarity NPD6777 Approved
0.7296 Intermediate Similarity NPD6776 Approved
0.7296 Intermediate Similarity NPD6782 Approved
0.7296 Intermediate Similarity NPD6780 Approved
0.7296 Intermediate Similarity NPD6778 Approved
0.7296 Intermediate Similarity NPD6779 Approved
0.7283 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD4287 Approved
0.7273 Intermediate Similarity NPD7697 Approved
0.7273 Intermediate Similarity NPD7435 Discontinued
0.7273 Intermediate Similarity NPD7698 Approved
0.7273 Intermediate Similarity NPD7696 Phase 3
0.7251 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD447 Suspended
0.7243 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD1471 Phase 3
0.7219 Intermediate Similarity NPD2799 Discontinued
0.7214 Intermediate Similarity NPD7701 Phase 2
0.7212 Intermediate Similarity NPD7907 Approved
0.7209 Intermediate Similarity NPD4628 Phase 3
0.7186 Intermediate Similarity NPD1613 Approved
0.7186 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD7685 Pre-registration
0.7176 Intermediate Similarity NPD5408 Approved
0.7176 Intermediate Similarity NPD1551 Phase 2
0.7176 Intermediate Similarity NPD5406 Approved
0.7176 Intermediate Similarity NPD5404 Approved
0.7176 Intermediate Similarity NPD5405 Approved
0.7169 Intermediate Similarity NPD2313 Discontinued
0.7159 Intermediate Similarity NPD5403 Approved
0.7143 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7874 Approved
0.7143 Intermediate Similarity NPD230 Phase 1
0.7136 Intermediate Similarity NPD6823 Phase 2
0.7112 Intermediate Similarity NPD7286 Phase 2
0.7111 Intermediate Similarity NPD5760 Phase 2
0.7111 Intermediate Similarity NPD5761 Phase 2
0.7108 Intermediate Similarity NPD3027 Phase 3
0.7108 Intermediate Similarity NPD7801 Approved
0.7107 Intermediate Similarity NPD7700 Phase 2
0.7107 Intermediate Similarity NPD7699 Phase 2
0.7101 Intermediate Similarity NPD6651 Approved
0.7079 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD2296 Approved
0.7066 Intermediate Similarity NPD3764 Approved
0.7066 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD5401 Approved
0.7045 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD6535 Approved
0.7041 Intermediate Similarity NPD6534 Approved
0.7037 Intermediate Similarity NPD5953 Discontinued
0.7035 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD4111 Phase 1
0.7033 Intermediate Similarity NPD4665 Approved
0.7022 Intermediate Similarity NPD1653 Approved
0.7012 Intermediate Similarity NPD6696 Suspended
0.7 Intermediate Similarity NPD7240 Approved
0.6979 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6971 Remote Similarity NPD6190 Approved
0.697 Remote Similarity NPD1470 Approved
0.6964 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6952 Remote Similarity NPD2403 Approved
0.6933 Remote Similarity NPD1201 Approved
0.6931 Remote Similarity NPD7680 Approved
0.6919 Remote Similarity NPD4361 Phase 2
0.6919 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6919 Remote Similarity NPD4308 Phase 3
0.6915 Remote Similarity NPD2494 Approved
0.6915 Remote Similarity NPD2493 Approved
0.6914 Remote Similarity NPD7003 Approved
0.6914 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6889 Remote Similarity NPD7458 Discontinued
0.6887 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6886 Remote Similarity NPD9494 Approved
0.6882 Remote Similarity NPD8127 Discontinued
0.6878 Remote Similarity NPD7177 Discontinued
0.6869 Remote Similarity NPD4360 Phase 2
0.6869 Remote Similarity NPD4363 Phase 3
0.6864 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6864 Remote Similarity NPD3268 Approved
0.6848 Remote Similarity NPD4749 Approved
0.6848 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6845 Remote Similarity NPD4908 Phase 1
0.6842 Remote Similarity NPD1933 Approved
0.6836 Remote Similarity NPD3300 Phase 2
0.6832 Remote Similarity NPD3452 Approved
0.6832 Remote Similarity NPD3450 Approved
0.6831 Remote Similarity NPD8455 Phase 2
0.6829 Remote Similarity NPD7584 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data